Charles Schwab’s Allergan Inc AGN Stock Holding History

Charles Schwab’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-780,387	Closed	-$166M	–	3139
2014 Q4	$166M	Buy	780,387 +14,536	+2%	+$2.89M	0.25%	79
2014 Q3	$136M	Buy	765,851 +69,744	+10%	+$11.6M	0.22%	87
2014 Q2	$118M	Buy	696,107 +14,806	+2%	+$2.31M	0.2%	100
2014 Q1	$84.5M	Buy	681,301 +44,495	+7%	+$5.42M	0.15%	134
2013 Q4	$70.7M	Buy	636,806 +16,979	+3%	+$1.62M	0.13%	155
2013 Q3	$56.3M	Buy	619,827 +14,738	+2%	+$1.32M	0.11%	178
2013 Q2	$50.8M	Buy	+605,089	New	+$62.8M	0.11%	182

Other funds holding AGN

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return

ECM

Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return

HFS

HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Charles Schwab's AGN Position: Q1 2015 in Review

Charles Schwab sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 780,387 shares — an estimated $166M sold.

Charles Schwab first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $166M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

Charles Schwab reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
Charles Schwab sold 780,387 Allergan Inc shares in Q1 2015, an estimated $166M.
Charles Schwab first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
Charles Schwab's Allergan Inc position peaked at $166M in Q4 2014.
5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Charles Schwab's 13F filing for Q1 2015, filed 14 May 2015.